Wednesday
SESSION 26: CRITICAL EVALUATION OF CAROTID TREATMENT ACUTE STROKES AND CAROTID ARTERY STENTING (CAS) AS OF NOVEMBER 2013: WHERE ARE THEY GOING
SESSION 26 SCHEDULE
STATUS OF ACUTE STROKE TREATMENT
1:54 PM - 1:59 PM How Well Are The New Endovascular Devices Working For Treatment Of Acute Strokes: Why The Negative Results Of The Recent Trials (MR RESCUE, IMS And SYNTHESIS XP) With The Solitaire, Trevo, Merci And Penumbra Devices May Not Be The Last Word
  Presenter(s):L. Nelson Hopkins, MD  
  View Abstract      
2:00 PM - 2:05 PM Who Could (And Should) Perform Acute Stroke Interventions
  Presenter(s):Horst Sievert, MD  
2:06 PM - 2:11 PM Update On Endovascular Techniques And Results Of Carotid And Cerebral Artery Thrombectomy For Acute Strokes: How It Can Be Done Safely And Effectively And What Is The Risk: Experience In >150 Patients
  Presenter(s):Klaus D. Mathias, MD  
STATUS OF CAROTID ARTERY STENTING (CAS)
2:12 PM - 2:17 PM Improved Technology For CAS Will Improve CAS Outcomes: Why Membrane/Mesh Covered Stents And Flow Reversal Will Make A Difference: What Is Their Status
  Presenter(s):Claudio J. Schonholz, MD  
2:18 PM - 2:23 PM DEBATE: CREST Justifies Increased Usage Of CAS For Symptomatic And Asymptomatic Patients With Carotid Stenosis
  Presenter(s):William A. Gray, MD  
2:24 PM - 2:29 PM DEBATE: Nonsense: CREST Does Not Justify Increased Usage Of CAS For Symptomatic And Asymptomatic Carotid Stenosis
  Presenter(s):Michel Makaroun, MD  
2:30 PM - 2:35 PM What Is The Real Meaning Of Minor Strokes As Defined In CREST: Do They Matter More Than A Minor MI
  Presenter(s):Emmanuel M. Houdart, MD  
2:36 PM - 2:41 PM DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CEA Is Best And Does Not Increase Procedural Risk
  Presenter(s):A. Ross Naylor, MD, FRCS  
2:42 PM - 2:47 PM DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CAS Is Best And Can Be Done Safely
  Presenter(s):Barry T. Katzen, MD  
2:48 PM - 2:53 PM What Is The Best Current Treatment For Recently Symptomatic Carotid Stenosis: CAS Or CEA: Based On Combined Data From RCTs
  Presenter(s):Gustav Fraedrich, MD  
ASYMPTOMATIC CAROTID STENOSIS
2:54 PM - 2:59 PM DEBATE: Few If Any Patients Benefit From CEA Or CAS For Asymptomatic Carotid Stenosis In The Properly Used Statin Era
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
3:00 PM - 3:05 PM DEBATE: Not So! Many Asymptomatic Carotid Stenosis Patients Benefit From CAS And CEA: Which Ones
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
3:06 PM - 3:11 PM Asymptomatic Carotid Stenosis Can Progress And Become Symptomatic In A Substantial Proportion Of Patients
  Presenter(s):Richard P. Cambria, MD / Glenn M. LaMuraglia, MD / Mark Conrad, MD  
3:12 PM - 3:17 PM New Insights Into Selecting Asymptomatic Carotid Stenosis Patients At High Stroke Risk Who Should Have CAS Or CEA: The Importance Of Juxtaluminal Black Areas (JBAs)
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Abstract      
3:18 PM - 3:23 PM How To Pick High Risk Asymptomatic Carotid Stenosis Patients For CAS Or CEA: The Importance Of Transcranial Doppler Hits
  Presenter(s):J. David Spence, MD  
  View Abstract      
3:24 PM - 3:29 PM How To Pick Asymptomatic Carotid Stenosis Patients For CAS: What Percentage Of All Asymptomatic High Grade Lesions Should Be Treated
  Presenter(s):Sriram S. Iyer, MD  
3:30 PM - 3:40 PM Panel Discussion
3:40 PM - 4:00 PM Break - 40th Anniversary Celebration
(Cocktails Will Be Served)
Rhinelander Gallery (2nd Floor)
END OF SESSION 26
previous next